title: Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade.
authors.forename: M
authors.initials: M
authors.lastname: Mohr
authors.forename: A M
authors.initials: AM
authors.lastname: Jacobi
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000453:epidemiology*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D004359:Drug Therapy, Combination; D004417:Dyspnea / Q000188:drug therapy; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use; D000077339:Leflunomide; D017563:Lung Diseases, Interstitial / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000453:epidemiology*; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010456:Peptides, Cyclic / Q000037:antagonists & inhibitors / Q000097:blood / Q000276:immunology; D011859:Radiography; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors*; D012217:Rheumatoid Factor / Q000097:blood; D013256:Steroids / Q000627:therapeutic use
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D007555:Isoxazoles; D010456:Peptides, Cyclic; D019947:Receptors, Interleukin-6; D013256:Steroids; C487763:cyclic citrullinated peptide; D012217:Rheumatoid Factor; D000077339:Leflunomide; C502936:tocilizumab; D008727:Methotrexate